Pages that link to "Q26825464"
Jump to navigation
Jump to search
The following pages link to Current status and future prospects for epigenetic psychopharmacology (Q26825464):
Displaying 34 items.
- Childhood exposure to violence and lifelong health: clinical intervention science and stress-biology research join forces (Q24629111) (← links)
- Beyond the monoaminergic hypothesis: neuroplasticity and epigenetic changes in a transgenic mouse model of depression (Q24629465) (← links)
- Treatment-resistant schizophrenia: current insights on the pharmacogenomics of antipsychotics (Q28079065) (← links)
- From promises to practical strategies in epigenetic epidemiology (Q33356105) (← links)
- Molecular dynamics simulations indicate an induced-fit mechanism for LSD1/CoREST-H3-histone molecular recognition (Q34243848) (← links)
- Methylome-wide association study of schizophrenia: identifying blood biomarker signatures of environmental insults (Q35090701) (← links)
- Whole genome methylation analyses of schizophrenia patients before and after treatment (Q35614046) (← links)
- Effect of valproic acid on mitochondrial epigenetics (Q36165223) (← links)
- Methods to analyze big data in pharmacogenomics research (Q36404935) (← links)
- Epigenetic studies of schizophrenia: progress, predicaments, and promises for the future (Q36471524) (← links)
- High quality methylome-wide investigations through next-generation sequencing of DNA from a single archived dry blood spot (Q37089523) (← links)
- Methylomic analysis of monozygotic twins discordant for autism spectrum disorder and related behavioural traits (Q37529899) (← links)
- Epigenetic studies in Alzheimer's disease: current findings, caveats, and considerations for future studies (Q37626479) (← links)
- Combining redox-proteomics and epigenomics to explain the involvement of oxidative stress in psychiatric disorders (Q38019745) (← links)
- Lost in translation. New unexplored avenues for neuropsychopharmacology: epigenetics and microRNAs (Q38068561) (← links)
- Epigenetics and depressive disorders: a review of current progress and future directions (Q38365358) (← links)
- The epigenetics of aging and neurodegeneration. (Q38527233) (← links)
- Traumatic stress and human DNA methylation: a critical review. (Q38537763) (← links)
- Understanding epigenetic architecture of suicide neurobiology: A critical perspective (Q39005702) (← links)
- Epigenetics at the crossroads between genes, environment and resilience in anxiety disorders. (Q39312328) (← links)
- DNA methylation signatures of mood stabilizers and antipsychotics in bipolar disorder (Q47593705) (← links)
- S-Adenosyl Methionine in the Therapy of Depression and Other Psychiatric Disorders (Q47946109) (← links)
- Epigenetic regulation of melatonin receptors in neuropsychiatric disorders. (Q48088836) (← links)
- Recent Progress in Pharmacogenomics of Antipsychotic Drug Response. (Q52626353) (← links)
- Repeated treatment with electroconvulsive seizures induces HDAC2 expression and down-regulation of NMDA receptor-related genes through histone deacetylation in the rat frontal cortex. (Q53292303) (← links)
- Preclinical epigenetic models for screening epigenetic drugs for schizophrenia. (Q53817798) (← links)
- Biological Predictors of Clozapine Response: A Systematic Review (Q57174550) (← links)
- (Q57291624) (← links)
- (Q57291635) (← links)
- The Relationship between DNA Methylation and Antidepressant Medications: A Systematic Review (Q89510117) (← links)
- Chromatin profiling of cortical neurons identifies individual epigenetic signatures in schizophrenia (Q90781310) (← links)
- Opportunities and challenges in psychopharmacology (Q95579807) (← links)
- The "systems approach" to treating the brain: opportunities in developmental psychopharmacology (Q95579837) (← links)
- User:Daniel Mietchen/Wikidata lists/Long words in work titles (← links | edit)